ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia
Jennifer Neiss,
Lisa Hemetsberger,
Carolin Schaefer,
Marc Rijksen,
Antonia Schwab,
Armin Zebisch,
Andreas Reinisch,
Heinz Sill,
Annkristin Heine,
Albert Wölfler
Wiley ·
2026-11-09
· DOI 10.1002/cam4.72497
⬢ Cited by: 0Crossref
The publisher did not provide an abstract — full text is available via the link below.
Jennifer Neiss, Lisa Hemetsberger, Carolin Schaefer, Marc Rijksen, Antonia Schwab, Armin Zebisch et al. ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia. // Cancer Medicine. – 2026. – DOI: 10.1002/cam4.72497. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cam4.72497?af=R
Jennifer Neiss, Lisa Hemetsberger, Carolin Schaefer, Marc Rijksen, Antonia Schwab, Armin Zebisch, Andreas Reinisch, Heinz Sill, Annkristin Heine, & Albert Wölfler (2026). ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia. Cancer Medicine. https://doi.org/10.1002/cam4.72497
Jennifer Neiss, et al. “ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.” Cancer Medicine, 2026. doi:10.1002/cam4.72497.
@article{Neiss2026,
title = {ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia},
author = {Neiss, Jennifer and Hemetsberger, Lisa and Schaefer, Carolin and Rijksen, Marc and Schwab, Antonia and Zebisch, Armin and Reinisch, Andreas and Sill, Heinz and Heine, Annkristin and Wölfler, Albert},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72497},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cam4.72497?af=R}
}